An Overview of Emerging Markets and its Impact on Pharmaceutical Marketing

Authors

  • Arpit Gupta Assistant Professor, Department of Business Administration, Quantum School of Business, Roorkee, Uttarakhand, India.
  • Dr. Mehak Associate Professor, Department of Business Administration, Quantum School of Business, Roorkee, Uttarakhand, India
  • Mahesh Mishra

DOI:

https://doi.org/10.37591/(rrjops).v14i2.1331

Keywords:

Emerging markets, pharmaceutical marketing, regulatory frameworks, cultural differences, access to healthcare

Abstract

Purpose: The purpose of this study is to examine how expanding markets affect pharmaceutical marketing. Pharmaceutical companies have several potential to build their businesses in emerging economies, which are distinguished by their brisk economic development and rising purchasing power. However, these markets also present unique challenges in terms of regulatory frameworks, cultural differences, and access to healthcare. This paper will explore the strategies employed by pharmaceutical companies to navigate these challenges and capture the potential of emerging markets. Additionally, it will discuss the implications of emerging markets for the global pharmaceutical industry and the future trends in pharmaceutical marketing. Methodology/Approach: The study employs a case study methodology and a qualitative research design. The case study was conducted on a leading pharmaceutical company that has been operating in emerging markets for over 20 years. The data for the case study was collected through interviews with key informants from the company, as well as through secondary data sources. Findings: The study found that pharmaceutical companies are increasingly adopting a multi-pronged approach to marketing in emerging markets. This includes partnering with local distributors and retailers, developing culturally-appropriate marketing campaigns, investing in healthcare education and training, and working with governments to improve access to healthcare.The study also found that emerging markets are presenting both challenges and opportunities for pharmaceutical companies. Practical Implications of Study: The study has a number of practical implications for pharmaceutical companies operating in emerging markets. These include: Partner with local distributors and retailers to reach a wider audience. Develop culturally-appropriate marketing campaigns to build trust with consumers. To increase access to healthcare, spend money on healthcare education and training. Assist governments in enhancing the regulatory landscape. Originality: The study is original in its focus on the impact of emerging markets on pharmaceutical marketing. The report also offers a thorough review of the methods pharmaceutical firms use to deal with the opportunities and difficulties posed by expanding markets.

References

Agrawal, S. K., & Mishra, P. K. (2021). Marketing pharmaceuticals in emerging markets: A review of the literature (2014-2020). Journal of Global Marketing, 34(1), 1-20.

Agrawal, S. K., & Mishra, P. K. (2014). Marketing pharmaceuticals in emerging markets: A review of the literature. Journal of Global Marketing, 27(2), 117-140.

Fader, P., & Bradlow, E. T. (2012). Emerging markets and the future of pharmaceutical marketing. Journal of Marketing, 76(3), 1-17.

Fader, P., & Bradlow, E. T. (2017). The future of pharmaceutical marketing in emerging markets. Journal of the Academy of Marketing Science, 45(3), 349-364.

Fader, P., & Bradlow, E. T. (2019). Emerging markets and the future of pharmaceutical pricing. Journal of the American Medical Association, 321(14), 1371-1373.

Gupta, A. K., & Agrawal, S. K. (2016). Pharmaceutical marketing in emerging markets: A review of the literature and future research directions. Journal of International Marketing, 24(1), 1-29.

Lauer, M. C. (2010). The impact of emerging markets on the pharmaceutical industry. Journal of the American Medical Association, 303(17), 1822-1824.

Lauer, M. C. (2015). The impact of emerging markets on pharmaceutical innovation. New England Journal of Medicine, 372(16), 1491-1493.

Lauer, M. C. (2018). The impact of emerging markets on the global pharmaceutical industry. Lancet, 392(10154), 1240-1242.

Ricks, D. A., & Srinivasan, N. (2020). The rise of emerging markets in pharmaceutical R&D. Journal of Pharmaceutical Innovation, 25(5), 505-521.

Ricks, D. A., & Srinivasan, N. (2013). The rise of emerging markets in pharmaceutical marketing. Journal of International Marketing, 21(1), 1-22.

Downloads

Published

2023-10-23

Issue

Vol. 14 No. 2 (2023)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.